-
Increasing HIV In Women Is A Key Driver For The Cervical Cancer Drugs Market
13 Oct 2021 09:08 GMT
… drugs ease the localized treatment of cervical cancer … Pharmaceuticals for Human Use (ICH)'s Clinical Trials … -cancer-drugs-global-market-report
Kidney Cancer Drugs Global … Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient (Pazopanib …
-
eFFECTOR Therapeutics Stock Gains On Encouraging Preclinical Zotatifin Data In Breast Cancer
08 Oct 2021 12:00 GMT
… with Baylor College of Medicine, announced the presentation … on Molecular Targets and Cancer Therapeutics.
Zotatifin is … combination treatment of zotatifin with the mTOR inhibitor Novartis AG … 's (NYSE: NVS) Afinitor (everolimus …
-
Breckenridge Announces Launch of its 10mg strength for Everolimus Tablets (generic for Afinitor(R))
01 Oct 2021 13:09 GMT
… (generic for Afinitor®). The U.S. Food and Drug Administration previously granted … Limited is a global generic pharmaceutical research, development, manufacturing and … their respective owners.
Source: Breckenridge Pharmaceutical
Issuer of this News Release …
-
Global Lung Cancer Drugs Market Trends, Strategies, And Opportunities In The Lung Cancer Drugs Market 2021-2030
13 Sep 2021 10:54 GMT
… the possible treatments for lung cancer include surgery, … Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc. … ;bladder-cancer-drugs-global-market-report
Kidney Cancer Drugs Global … (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient (Pazopanib), …
-
Global Urology Medical Lasers Market Trends, Strategies And Opportunities In The Urology Medical Lasers Market 2021-2030
02 Sep 2021 10:58 GMT
… Urology medical lasers are used in the treatment of medical conditions … the Urology Medical Lasers Global Market Report 2021:
Kidney Cancer Drugs Global Market … (Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient (Pazopanib), Avastin …
-
Global Kidney Cancer Drugs Market Trends, Strategies, And Opportunities In The Kidney Cancer Drugs Market 2021-2030
06 Aug 2021 06:07 GMT
… immunocompromised treatments. The kidney cancer drugs market … drug administration (FDA) approval to combine their drug … ), Sutent (Sunitinib), Afinitor (Everolimus), Votrient ( … Kidney Cancer Drugs Market Organizations Covered: Bayer AG, Pfizer Inc., Novartis …
-
Merkc & Co announces results at ASCO for Keytruda plus Lenvima for kidney cancer patients
07 Jun 2021 15:57 GMT
… most common form of kidney cancer.
The new data, … Novartis’ Afinitor (everolimus) versus Sutent (sunitinib) for the first-line treatment … ;KEYNOTE-581 trial and further supports … treatment option for patients with this disease,” said Takashi Owa, chief medicine …
-
Novartis (NVS) Q1 Earnings & Sales Miss Estimates on COVID
27 Apr 2021 17:53 GMT
… Within this segment, the Pharmaceuticals business unit was flat … competition for Glivec, Afinitor and Exjade. Sales … cancer whose cancer progressed while on or after previous treatments.
Novartis … mRNA and bulk drug product for the vaccine candidate, CVnCoV …
-
Renal Cell Cacinoma Drugs Market Report Size 2021 Growth, Share, Product Types and Application, Top Key Players with Sales, Price, Business Overview, SWOT Analysis 2026
23 Apr 2021 05:11 GMT
… Renal Cell Cacinoma Drugs launching and Market … Genentech ● Immatics Biotechnologies ● AVEO Oncology ● Eisai ● Acceleron ● Rexahn Pharmaceuticals ● Bionomics … Votrient(Pazopanib) ● Avastin(Bevacizumab) ● Afinitor(Everolimus) ● Inlyta(Axitinib) ● Torisel …
-
HUTCHMED Initiates a Phase Ib/II Trial of Surufatinib in Combination with Tislelizumab in Patients with Advanced Solid Tumors
24 Mar 2021 07:00 GMT
… pNET only) and Afinitor® for pNET and … trials and two pivotal Phase 2 trials. In January 2021, BeiGene and Novartis … treatment of cancer and immunological diseases. It has advanced ten cancer drug … approvals and commercializing pharmaceutical products and …
About
© 1995-2021